We determined the in vivo growth of the different ERp46-manipulated subclones of RCC RAG cells after subcutaneous injection into nude mice (n = 7/group) which achieved a tumor take rate of 100%. This evidence concerns the gene TXNDC5 and renal cell carcinoma.